On the State and Federal level, legislation is passed every year that affects our access to healthcare as well as the quality and affordability of our health care. We fight for legislation that will improve the health of all adults and children across the country.
We oppose H.J. Res 77 and any other efforts to single out the Food and Drug Administration for funding. Our organizations represent millions of patients, consumers, health professionals, and scientists who strongly support the work of the FDA and urge Congress to provide the level of appropriations the agency needs throughout FY 2014.
Letter to House Leaders in Opposition to H.J. Res 77 Read More »
We strongly support the FDA’s ban on importing drugs manufactured at Ranbaxy Laboratories, Ltd.’s facility in Mohali, India. The company’s facility is not complying with current good manufacturing practices (cGMP), which are the main regulatory safeguard to ensure drug manufacturing quality.
We re very supportive of the Patient Protection and Affordable Care Act (ACA). We were extremely disappointed that the Hatch-Klobuchar amendment (S. Amdt. 297 to S. Con. Res. 8 ) to repeal the 2.3% excise tax on medical devices was overwhelmingly supported. Thank you very much for your important vote against the amendment. We are writing to ask for a meeting with your staff to discuss this issue.
Letter to Key U.S. Senators in Support of Funding for the Affordable Care Act Read More »
The Coalition writes to Congresswoman DeLauro to strongly support the “Healthy Families Act”, which creates a national standard for paid sick days.
Letter to Congresswoman Rosa DeLauro in Support of the “Healthy Families Act” Read More »
The Coalition writes to Chairman Tom Harikin to strongly support the “Healthy Families Act”, which creates a national standard for paid sick days.
Letter to Senator Tom Harkin in Support of the “Healthy Families Act” Read More »
The Patient, Consumer, and Public Health Coalition, we strongly oppose efforts to delay or repeal the 2.3% excise tax on medical devices. The excise tax was included in the Patient Protection and Affordable Care Act (ACA), so that it would help to pay for benefits such as affordable health insurance for currently uninsured and underinsured Americans. The Affordable Care Act will greatly benefit medical device manufacturers because more patients and consumers will have coverage that will enable them to afford medical devices.
The Patient, Consumer, and Public Health Coalition, strongly urges CMS to release the Sunshine Act final regulations as quickly as possible. Public interest groups and members of Congress agree that it is past time to release the regulations and start collecting information on industry payments to healthcare providers.
Letter to CMS urging the release of the Sunshine Act final regulations Read More »
The Patient, Consumer, and Public Health Coalition thanks the HELP Committee for the opportunity to comment on draft legislation.
Letter to HELP Committee on Track and Trace Legislation Read More »
The Patient, Consumer, and Public Health Coalition thanks Congressman Markey on his commitment to the health of patients and consumers by introducing the Verifying Authority and Legality in Drug (VALID) Compounding Act of 2012. This bill would strengthen FDA oversight of compounding pharmacies in several essential ways, and is clearly needed to prevent tragedies such as the contaminated steroid injections that have already resulted in 356 cases of fungal meningitis and 28 deaths.
Letter to Congressman Edward J. Markey on the VALID Compounding Act of 2012 Read More »
The Patient, Consumer, and Public Health Coalition writes to strongly oppose the use of ASTM International Standard (F1917-12) as a safety standard for baby bumper pads. The standard is not a useful alternative to the Department of Health and Mental Hygiene’s (DHMH) proposed ban.
